Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates. Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium. For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register. For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.
Patent details
3327027
Title:
PEPTIDES CYTOTOXIQUES ET CONJUGUES ANTICORPS-MEDICAMENTS DE CEUX-CI
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic information
Application number:
172018293
WO application number:
Type:
European patent granted for BE
Status:
Open
Publication number:
3327027
WO publication number:
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:
Dates
Filing date:
07/11/2012
Grant date:
06/01/2021
EP publication date:
30/05/2018
WO publication date:
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
06/01/2021
EP B1 publication date:
06/01/2021
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
07/11/2032
Applicant
1
Name:
Pfizer Inc.
Legal Form:
From:
16/03/2023
Address:
66 Hudson Boulevard East, New York, NY 10001‐2192 , United States (US)
To:
2
Name:
Pfizer Inc.
Legal Form:
From:
06/01/2021
Address:
235 East 42nd Street, New York, NY 10017, United States (US)
To:
16/03/2023
Agent
1
Name:
GEVERS PATENTS
Legal Form:
From:
08/02/2024
Address:
De Kleetlaan 7A, 1831, DIEGEM, Belgium (BE)
To:
2
Name:
GEVERS PATENTS
Legal Form:
From:
11/03/2021
Address:
Holidaystraat 5, 1831, DIEGEM, Belgium (BE)
To:
08/02/2024
Inventor
1
Name:
DOROSKI, Matthew David
Legal Form:
Address:
Mystic, CT Connecticut 06355, United States (US)
2
Name:
MADERNA, Andreas
Legal Form:
Address:
Stony Point, NY New York 10980, United States (US)
3
Name:
O'DONNELL, Christopher John
Legal Form:
Address:
Mystic, CT Connecticut 06355, United States (US)
4
Name:
SUBRAMANYAM, Chakrapani
Legal Form:
Address:
South Glastonbury, CT Connecticut 06073, United States (US)
5
Name:
VETELINO, Beth Cooper
Legal Form:
Address:
North Stonington, CT Connecticut 06359, United States (US)
6
Name:
DUSHIN, Russell George
Legal Form:
Address:
Old Lyme, CT Connecticut 06371, United States (US)
7
Name:
STROP, Pavel
Legal Form:
Address:
San Mateo, CA California 94402, United States (US)
8
Name:
GRAZIANI, Edmund, Idris
Legal Form:
Address:
Chestnut Ridge, CT Connecticut 10977, United States (US)